Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort StudyThomas Benfield, Hanne Rolighed Christensen, Jens Lundgren et al.|Clinical Infectious Diseases|2021Cited by 93
Venous Thromboembolism and Major Bleeding in Patients With Coronavirus Disease 2019 (COVID-19): A Nationwide, Population-Based Cohort StudyMichael Dalager‐Pedersen, Jacob Bodilsen, Lars Christian Lund et al.|Clinical Infectious Diseases|2021Cited by 49
Positive Predictive Value of ICD-10 Diagnosis Codes for COVID-19Jacob Bodilsen, Lars Haukali Omland, Steffen Leth et al.|Clinical Epidemiology|2021Cited by 35
Treatment effect modifiers in hospitalised patients with COVID-19 receiving remdesivir and dexamethasoneCæcilie Leding, Thomas Benfield, Jacob Bodilsen et al.|Scandinavian Journal of Infectious Diseases|2023Cited by 7
The impact of age and obesity on outcomes among patients hospitalized with COVID‐19 in Denmark: A nationwide cohort studyAnton Lund Andersen, Jens Meldgaard Bruun, Sigrid Bjerge Gribsholt et al.|Obesity Science & Practice|2023Cited by 4